Failure to detect human papillomavirus in Kaposi's sarcoma.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 1351572)

Published in Lancet on June 27, 1992

Authors

R J Biggar, N Dunsmore, R J Kurman, K V Shah, J Kordor, F Cottoni, A Hatzakis, P L Gigase

Articles by these authors

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol (1999) 40.46

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst (2000) 14.43

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48

Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14

Association of cancer with AIDS-related immunosuppression in adults. JAMA (2001) 6.80

Spectrum of AIDS-associated malignant disorders. Lancet (1998) 5.30

Determinants of retrovirus (HTLV-III) antibody and immunodeficiency conditions in homosexual men. Lancet (1984) 4.68

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol (1991) 4.62

Seroepidemiology of HTLV-III antibody in Danish homosexual men: prevalence, transmission, and disease outcome. Br Med J (Clin Res Ed) (1984) 4.39

Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol (1995) 4.33

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04

HIV transmission through breastfeeding: a study in Malawi. JAMA (1999) 4.00

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77

Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70

Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis (1999) 3.69

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases. Am J Surg Pathol (1996) 3.63

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA (1996) 3.50

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer (1985) 3.50

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA (1999) 3.37

Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31

Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis (2000) 3.20

Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol (2000) 2.96

Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol (1989) 2.94

Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med (1997) 2.81

Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74

High risk of HIV-1 infection for first-born twins. The International Registry of HIV-exposed Twins. Lancet (1991) 2.51

Generation of type-specific probes for the detection of single-copy human papillomavirus by a novel in situ hybridization method. Mod Pathol (1998) 2.50

Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med (1986) 2.47

Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst (1987) 2.45

HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report. Euro Surveill (2011) 2.42

High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis (1973) 2.40

Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery (2001) 2.35

Trends in HIV incidence among young adults in the United States. JAMA (1998) 2.28

The AIDS problem in Africa. Lancet (1986) 2.25

A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24

Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer (2001) 2.22

Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer (2001) 2.12

Viral etiology of juvenile- and adult-onset squamous papilloma of the larynx. Proc Natl Acad Sci U S A (1982) 2.11

Clear-cell adenocarcinoma of the genital tract in young females. Registry report. N Engl J Med (1972) 2.11

Long-term seropositivity for human T-lymphotropic virus type III in homosexual men without the acquired immunodeficiency syndrome: development of immunologic and clinical abnormalities. A longitudinal study. Ann Intern Med (1986) 2.06

Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ (1997) 2.03

Common structural antigen of papovaviruses of the simian virus 40-polyoma subgroup. J Virol (1977) 2.02

Solid tumors after chronic lymphocytic leukemia. Blood (2001) 2.01

Pseudomyxoma peritonei syndrome. Adv Surg (1996) 1.99

The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol (2001) 1.98

Public perceptions in relation to intention to receive pandemic influenza vaccination in a random population sample: evidence from a cross-sectional telephone survey. Euro Surveill (2009) 1.98

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst (1996) 1.96

Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol (1998) 1.93

Variation in human T lymphotropic virus III (HTLV-III) antibodies in homosexual men: decline before onset of illness related to acquired immune deficiency syndrome (AIDS). Br Med J (Clin Res Ed) (1985) 1.93

Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med (1991) 1.91

Projections of the incidence of non-Hodgkin's lymphoma related to acquired immunodeficiency syndrome. J Natl Cancer Inst (1991) 1.91

Immunologic identification of papillomavirus antigen in condyloma tissues from the female genital tract. Obstet Gynecol (1980) 1.90

Epstein-Barr virus RNA in Burkitt tumor tissue. Cell (1979) 1.88

ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet (1985) 1.85

A new tumour-derived transforming strain of Epstein-Barr virus. Nature (1978) 1.84

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer (1997) 1.82

Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ (1990) 1.81

Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis (1998) 1.79

Factors that could influence the spread of AIDS in Ghana, West Africa: knowledge of AIDS, sexual behavior, prostitution, and traditional medical practices. J Acquir Immune Defic Syndr (1991) 1.77

SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77

PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. Cancer Res (1998) 1.77

Interactions between persons at risk for AIDS and the general population in Denmark. Am J Epidemiol (1992) 1.76

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis (1993) 1.72

Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst (1997) 1.72

Preventing AIDS now. BMJ (1991) 1.71

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer (2007) 1.70

p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol (1997) 1.67

Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women. Clin Infect Dis (2001) 1.66

Sarcoma in a hamster inoculated with BK virus, a human papovavirus. J Natl Cancer Inst (1975) 1.65

Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol (1996) 1.65

Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. J Infect Dis (1999) 1.64

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol (1995) 1.64

Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. Hum Gene Ther (1999) 1.63

High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet (1994) 1.62

Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol (2001) 1.62

Short-term effects of air pollution on mortality in Athens. Int J Epidemiol (1986) 1.61

Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol (1997) 1.61

A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol (1997) 1.61

Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus. JAMA (1987) 1.60

Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol (1998) 1.59

Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol (1998) 1.58

Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am J Pathol (1991) 1.57

Human papillomavirus and epithelial ovarian neoplasia. Gynecol Oncol (1989) 1.56

Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis (1997) 1.56

Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women. Int J Gynecol Pathol (1997) 1.55

The clinical features of HIV infection in Africa. Br Med J (Clin Res Ed) (1986) 1.55

A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary. Am J Surg Pathol (2000) 1.54

Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus. Lancet (1987) 1.54

Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81. J Natl Cancer Inst (1984) 1.54

Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol (1987) 1.54

Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential. Hum Pathol (1995) 1.53

A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol (2000) 1.51

Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control (2000) 1.50